University of Michigan gets $10.7 million influx for cancer research
Cancer research at the University of Michigan will get a $10.7 million boost from the federal government, the university announced today.
U-M's Comprehensive Cancer Center said today that it would conduct a five-year study of colorectal cancer and pancreatic cancer after landing the National Cancer Institute's Specialized Program in Research Excellence (SPORE) grant. Scientists from nine departments at U-M's Medical School and School of Public Health will contribute to the research project.
U-M said its scientists would place a heavy emphasis on research that could lead to technological improvements that would benefit patients.
The project will involve research on preventing colorectal cancer; developing new pancreatic cancer treatments; fostering early detection of pancreatic cancer; and improving existing pancreatic cancer treatments.
“This grant represents a major effort to bridge the basic science to the clinic," said Dean Brenner, the lead researcher for the project and a professor of internal medicine and pharmacology at the U-M Medical School and the Ann Arbor VA Healthcare System, in a news release. "You have to have very good science, but it also has to translate: How are we going to use this information to help patients? The depth of expertise at the University of Michigan allows us to pursue this work."